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IgE is an ancient and highly conserved immunoglobulin isotype found in all mammals1. It is thought that IgE has evolved to provide protection against infection by macroparasites, such as helminths. 
However, although the abundance of IgE is elevated in both mice 
and humans with helminth infection, IgE is not critical for protective 
immunity against helminths, and much of the IgE raised is not para-
site specific2. An alternative hypothesis suggests that IgE is impor-
tant for immune responses to environmental toxins such as venoms3, 
and indeed, published data indicate that IgE can provide protection 
against bee venom and limit snake-venom toxicity4–6. Furthermore, 
aberrant IgE responses that cause allergies are frequently directed 
against environmental irritants and non-replicating agents. A role 
for IgE in defending the host against immediate danger would be 
consistent with the very rapid mobilization of its effector functions. 
Therefore, a broader paradigm proposes that IgE represents an arm 
of early immunological host defense against xenobiotics or large 
parasites that threaten tissue integrity7. However, what drives these 
IgE responses in vivo, what they recognize and whether they have a 
wider role in immunological defense remain unknown.
IgE responses occur most frequently in epithelial tissues such as 
the skin, lungs and gut, which contain resident IgE-binding cells. 
These barrier surfaces are continuously exposed to challenges 
from environmental xenobiotics, and a prominent feature of their 
response to external insults is the induction of type 2 immunity8 
and IgE9,10. In mouse skin epithelia, a resident γ δ TCR+ population 
of intraepithelial lymphocytes (IELs) controls tissue homeostasis via 
the induction of IL-1311, a type 2 cytokine, and also promotes IgE 
after challenge with protein allergens on stressed tissue12. These IELs 
can directly sense epithelial-cell dysregulation via stress-sensing 
receptors, such as NKG2D, and this pathway has a key role in pro-
moting the IgE response12,13. The ability of IELs to detect epithe-
lial-cell stress and initiate a restorative response has been called 
‘lymphoid stress surveillance’ and has an important role in the early 
detection of stressed and pre-malignant cells13. Indeed, tissue-spe-
cific IELs regulate epithelial tissue integrity and are key to protec-
tion of the host against carcinogenesis11,13.
Many toxins and xenobiotics are also carcinogens. Hence, in 
defending against environmental xenobiotics, IgE might simul-
taneously confer protection against transformation and against 
cancer in exposed tissues. Here we report the development of a 
potent and dominant IgE response following topical exposure to 
the common environmental xenobiotic and carcinogen DMBA 
(7,12-dimethylbenz[a]anthracene). This endogenous IgE response 
was autoreactive and was required for protection against cutaneous 
carcinogenesis. Furthermore, we found that tissue-resident γ δ TCR+ 
IELs had a unique role in initiating and regulating IgE production, 
driving an early, innate-like response, which directed a subsequent 
adaptive response supported by IL-4-producing CD4+ α β T cells. 
Deep sequencing of IgE and IgG1 from germinal-center (GC) B 
cells and plasma cells (PCs) indicated that γ δ TCR+ IELs shaped a 
distinct IgE repertoire that was dependent on the presence of DNA 
damage in epithelial cells. Thus, lymphoid stress surveillance pro-
moted a unique IgE response that was part of an early host-defense 
mechanism that provides protection against cancer.
Results
Carcinogen-induced epithelial-cell damage triggers IgE 
responses. DNA-damaging xenobiotics such as DMBA are 
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revealed that γ δ T cells shaped the IgE repertoire by supporting specific variable-diversity-joining (VDJ) rearrangements with 
unique characteristics of the complementarity-determining region CDRH3. This endogenous IgE response, via the IgE receptor 
Fcε RI, provided protection against epithelial carcinogenesis, and expression of the gene encoding Fcε RI in human squamous-
cell carcinoma correlated with good disease prognosis. These data indicate a joint role for immunosurveillance by T cells and by 
B cells in epithelial tissues and suggest that IgE is part of the host defense against epithelial damage and tumor development.
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commonly found in the environment and have been linked to 
carcinogenesis14,15. We found that a single topical application of 
DMBA to the back skin of wild-type mice induced an IgE response 
in serum within 4 d (Fig. 1a). Exposure to DMBA was associated 
with upregulation of the NKG2D ligand Rae-1 on skin epithelial 
cells (Supplementary Fig. 1a), indicative of epithelial-cell stress. 
The number of epithelial cells containing breaks in double-stranded 
DNA (dsDNA), assessed by staining for the phosphorylated his-
tone H2A variant H2AX (γ H2AX), peaked between 3 d and 7 d 
after exposure to DMBA (Supplementary Fig. 1b,c). Epidermal 
Langerhans cells (LCs) must metabolize DMBA to the more muta-
genic compound DMBA-trans-3,4-dihydrodiol to cause substantial 
damage to DNA. Langerin-DTA mice, which do not have LCs (and 
have transgenic expression of the gene encoding human Langerin, 
modified to drive expression of diphtheria toxin subunit A (DTA)), 
showed less epithelial-cell DNA damage following a single dose of 
DMBA16 than did their non-transgenic littermates (control mice) 
(Supplementary Fig. 1d) and failed to show increased serum IgE, 
in contrast to the control mice (Fig. 1b). However, Langerin-DTA 
mice generated IgE in response to other topical challenges12 and, 
when exposed to DMBA repeatedly, they developed both DNA 
damage and IgE responses (Supplementary Fig. 1d,e). Other DNA-
damaging skin challenges, such as ultraviolet (UV) irradiation, also 
induced IgE (Supplementary Fig. 1f,g). Once-weekly exposure to 
DMBA led to the development of papillomas and squamous-cell 
carcinomas (SCCs) after 8–15 weeks. This was associated with high 
concentrations of serum IgE, which rose progressively as epithe-
lial DNA damage accumulated (Fig. 1c). When DMBA was given 
daily for 5 d only, mice developed skin tumors, and their serum 
IgE showed a progressive increase for 12 weeks (Supplementary 
Fig. 1h). The systemic IgE responses were paralleled by the infil-
tration and accumulation of IgE in acutely damaged skin (Fig. 1d) 
and in skin tumors (Fig. 1d,e). The tissue IgE was carried mainly 
by basophils expressing Fcε RI, the high-affinity receptor for IgE 
(Fig. 1d). More mature transcripts encoding IgE were present in the 
tumor tissue than in the adjacent skin, indicative of some local IgE 
production, whereas transcripts encoding IgG1 and IgM were lower 
in abundance in tumors than in adjacent skin (Fig. 1f). These data 
indicated that the epithelial-cell damage triggered by exposure to 
DMBA potently promoted the production of IgE that accumulated 
in the resulting skin tumors.
Topical exposure to a carcinogen induces class switching in local 
B cells. To investigate the origin of the DMBA-induced IgE response, 
we assessed B cells in the skin-draining lymph nodes (LNs) during 
acute exposure to DMBA (before malignancy). Two applications 
of DMBA, 3 d apart, on the ear skin induced the enlargement of 
skin-draining LNs plus the formation of GCs and class switching 
of GC B cells (Fig. 2a), as well as an increased number of CD138+ 
PCs, which had class switched mainly to IgE and IgG1, with little or 
no induction of IgG2a (Fig. 2b). There was no induction of GCs or 
class-switched PCs in the spleen (data not shown), which suggested 
that the response was localized to the skin-draining LNs. Weekly 
exposure to DMBA on the back skin for 5 weeks also induced GCs 
and IgE+ and IgG1+ PCs. However, under these conditions, the 
GC structures and the IgG1+ PCs diminished from week 3, which 
resulted in a dominant IgE response (Fig. 2c). By week 5 after expo-
sure, nearly 80% of all CD138+ PCs in the LNs had switched to IgE 
(Fig. 2c). Thus, exposure of the skin to DMBA promoted a local type 
2 B cell response with dominant and prevailing production of IgE.
Carcinogen-induced IgE provides protection against carcinogen-
esis. To explore whether the IgE response induced by DMBA was 
important for host defense, we assessed skin-tumor formation in 
mice deficient in the gene encoding the heavy chain of IgE (Igh-7; 
called ‘Igh7’ here), which thus lack IgE. Following once-weekly 
exposure to DMBA, Igh7−/− mice developed tumors sooner and more 
rapidly than did their wild-type counterparts, as well as significantly 
more and larger tumors than those of their wild-type counterparts 
(Fig. 3a). The IgG1 response in the DMBA-treated Igh7−/− mice was 
identical to that of their wild-type counterparts (Supplementary 
Fig. 2a). In addition, the number of Fcε RI+ effector cells in their 
tissue was similar to that of wild-type mice (Supplementary Fig. 3a). 
Mice deficient in the gene encoding Fcε RI (Fcer1a−/− mice) also had 
enhanced susceptibility to DMBA carcinogenesis relative to that of 
wild-type mice (Fig. 3b), despite the finding of similar concentra-
tions of IgE and of IgG1 in serum from these mice (Supplementary 
Fig. 2b); this suggested that the protective effect of IgE was medi-
ated by signaling through Fcε RI. CD45locKit–Fcε RI+ basophils 
represented the main IgE+ cell population in the tumors (Fig. 1d). 
Cpa3Cre/+ mice, which have sequence encoding Cre recombinase 
inserted into the locus encoding mast-cell carboxypeptidase (Cpa3) 
and lack skin mast cells, showed susceptibility to tumor develop-
ment similar to that of their Cpa3+/+ littermates following DMBA 
carcinogenesis (Supplementary Fig. 3b), which suggested that most 
probably, Fcε RI+ basophils mediated the protection against carci-
nogenesis. Splenic CD45locKit–CD41+Fcε RI+ basophils from Igh7−/− 
mice produced IL-4 and IL-6 and degranulated equivalent to their 
wild-type counterparts after stimulation with the phorbol ester 
PMA and ionomycin; however, the skin-tumor cytokine microenvi-
ronment was significantly altered in Igh7−/− mice relative to that in 
wild-type mice (Supplementary Fig. 3c–e).
To investigate whether similar IgE responses occur in humans, 
we analyzed newly incised skin SSC samples from 12 patients. Fcε 
RI+ cells were present in all tumor and peri-lesional skin samples, 
varying in frequency from around 1% to over 40% of the tumor 
infiltrating CD45+ leukocytes (Fig. 3c). The Fcε RI+ cells were pres-
ent mainly in the peritumoral infiltrate at the interface between 
the stroma and the neoplastic keratinocytes, with some entering 
the tumor and/or hair follicle (average, 11.7 ± 2.9 cells per mm2 
(mean ± s.e.m.)) (Supplementary Fig. 4). Fcε RI+ cells accumulated 
more in the skin than in blood samples from the same donor; how-
ever, tumor tissue contained fewer Fcε RI+ cells than did histopatho-
logically ‘healthy’ peri-lesional skin from the same donor (Fig. 3c). 
In an additional cohort of 56 patients with SCC, gene-expression 
analysis revealed that expression of FCER1A mRNA was higher in 
unaffected skin areas than in developed tumors, with the lowest 
expression of FCER1A mRNA detected in high-risk and metastatic 
SCC (Fig. 3d). A significant linear trend was observed between the 
expression of FCER1A mRNA and the risk of more-advanced SSC 
(Fig. 3d). Together these data indicated that IgE, via Fcε RI, provided 
protection against DMBA-induced SCC and that the presence of 
fewer Fcε RI-expressing leukocytes in human SSC correlated with 
the risk of more-severe disease.
Carcinogen-induced humoral immunity depends on αβ T cell–
derived IL-4. Conventional and unconventional modes of induc-
ing class switching to IgE have been described8. We first explored 
whether induction of tumor-protective IgE was dependent on α β 
T cells. Mice deficient in the β -chain of the T cell antigen receptor 
(TCR) (Tcrb−/− mice), which lack α β T cells, had no enlargement 
of skin-draining LNs, no GCs and no IgG1+ or IgE+ PCs follow-
ing two topical applications of DMBA to the ear skin, in contrast to 
their wild-type counterparts (Fig. 4a). The response was restored 
by the transfer of polyclonal CD4+ T cells into Tcrb−/− mice, but 
not by the transfer of OT-II CD4+ T cells, which have transgenic 
expression of a major histocompatibility complex class II–restricted 
(ovalbumin-specific) TCR (Supplementary Fig. 5a); this indicated 
that it was dependent on a normal TCR repertoire. Furthermore, 
injection of blocking antibody to the B cell–stimulatory molecule 
CD40L partially inhibited LN enlargement and repressed GC for-
mation and the generation of IgE+ and IgG1+ PCs in wild-type mice 
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(Supplementary Fig. 5b). Similar defects in class switching to IgE+ 
and IgG1+ PCs were seen Il4−/− mice, which cannot produce IL-4, 
although Il4−/− mice showed an enlargement of LNs similar to that 
of wild-type mice and had some GC B cells (Fig. 4a). Il4−/− mice 
had some class switching to IgG2a, which was never observed in 
wild-type or in Tcrb−/− mice (data not shown). Chimeras generated 
 by the transfer of wild-type bone marrow into Il4−/− host mice 
(WT→ Il4−/− chimeras) underwent induction of IgE+ and IgG1+ 
PCs similar to the induction of such cells in WT→ WT chimeras 
following topical treatment with DMBA, whereas Il4−/−→ WT chi-
meras underwent significantly less induction of IgE+ and IgG1+ 
PCs than did WT→ Il4–/– chimeras (P < 0.0001 and P < 0.01, respec-
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Fig. 1 | Carcinogen-induced epithelial-cell damage triggers a rapid local and systemic IgE response. a–c, ELISA of IgE in serum from blood obtained  
from wild-type FVB mice (n =  10) (a) or from Langerin-DTA mice (n =  5) and their non-transgenic littermates (control mice) (NLC) (n =  4) (b) before 
treatment (Pre-bleed) and 4 d after treatment with a single topical dose of 200 nmol DMBA or vehicle control (Acetone) on shaved back skin (a,b) and 
from wild-type FVB mice (n =  9 per group) at various times (horizontal axis) before and after topical exposure to 200 nmol DMBA once weekly (c).  
d, Flow cytometry (left) of IgE-bearing cells in naive skin, skin 7 d after exposure to DMBA and DMBA-induced skin tumors (left margin), and quantification 
of those cells from such mice (right; cells in tumor presented as frequency among CD45+ cells): n =  5 mice (naive skin), n =  7 mice (DMBA-treated skin) 
and n =  6 mice (tumors). Numbers adjacent to outlined areas (left half) indicate percent CD45+IgE+ cells (far left) or CD45locKit–IgE+ cells (basophils) 
(left gate) and CD45hicKit+IgE+ cells (mast cells) (right gate) (middle left). e, Microscopy (tile scans) of IgE staining (red) in a DMBA-induced tumor; 
nuclei are blue. Scale bar, 1 mm. f, Quantitative RT-PCR analysis of mature transcripts encoding IgE, IgG1 or IgM in tumors or tumor-adjacent skin (key) in 
mice (n =  7 per group) after DMBA-induced carcinogenesis; results are presented relative to those of the control gene encoding cyclophylin. Each symbol 
(a–d,f) represents an individual mouse; small horizontal lines (d,) indicate the mean ( ±  s.e.m.). **P <  0.01, ***P <  0.001 and ****P <  0.0001 (two-tailed 
unpaired Student’s t-test (a,f), multiple t-tests (b) or one-way analysis of variance (ANOVA) testing for linear trend of IgE increase with time (c)). Data 
are representative of three (a,c,f), two (b) or four (d) independent experiments with similar results (a–d,f; mean ± s.e.m.) or are representative of six 
independent tumors (e).
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Fig. 2 | Topical exposure to a carcinogens induces local B cell class switching, which results in a dominant IgE response. a, Flow cytometry (middle) 
of GC gated B cells from the skin-draining LNs of wild-type FVB mice left untreated (Naive) or exposed topically to DMBA on the dorsal side of the ears 
twice, 3 d apart, and analyzed 7 d after the final exposure (DMBA), assessing class switching via intracellular immunoglobulin staining, and quantification 
of total LN cells (far left) and GC B cells (defined as B220+CD95+GL7+ LN cells throughout) (far right) in such mice (n =  9 (Naive) or n =  11 (DMBA)). 
Numbers adjacent to outlined areas (middle) indicate percent GL7+CD95+ cells (top row); IgE+IgG1– cells (left gate) and IgE–IgG1+ cells (right gate) 
(bottom left); or IgG2a+IgG1– cells (left gate) and IgG2a–IgG1+ cells (right gate) (bottom right). b, Flow cytometry (left) of PCs in the mice in a, with 
intracellular immunoglobulin staining for analysis of isotype switching, and quantification of IgG1+, IgE+ or IgG2a+ PCs (gated as FSChiCD95+CD138+  
cells throughout) in such mice (right). Numbers in outlined areas (left) indicate percent CD138+FSChi cells (PCs) (top row) or as in a (bottom row).  
c, Flow cytometry (right) of axillary LN B cells from wild-type FVB mice exposed to DMBA once weekly on shaved back skin, assessed at weeks 2–5 after 
exposure (above plots), and frequency of GC B cells (among B220+ lymphocytes) and IgG1+ or IgE+ (key) class-switched PCs (among CD138+ PCs) in such 
mice (n =  3 per time point) analyzed weekly for 1–5 weeks (horizontal axis) beginning 7 d after the final exposure (left). Numbers in outlined areas (right), 
as in a (bottom left). Each symbol (a,b) represents an individual mouse; small horizontal lines indicate the mean ( ±  s.e.m.). NS, not significant (P >  0.05); 
*P <  0.05, ***P <  0.001 and ****P <  0.0001 (two-tailed Student’s t-test for unpaired data). Data are from one experiment representative of five (a,b) or two 
(c) independent experiments with similar results (mean ±  s.e.m. in c).
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tively (two-tailed Student’s t-test for unpaired data); Supplementary 
Fig. 5c), which indicated that the IL-4 was derived from hematopoi-
etic cells, not from irradiation-resistant skin-resident cells. To deter-
mine whether the requirement for α β T cells in class switching to 
IgE and/or IgG1 reflected a need for IL-4, we reconstituted Tcrb−/− 
mice with wild-type or Il4−/− CD4+ T cells 24 h before exposing the 
host mice to DMBA. Only the wild-type CD4+ α β T cells were able 
to restore the GC response and the production of IgG1 and/or IgE 
in the skin-draining LNs of the reconstituted Tcrb−/− mice (Fig. 4b). 
Moreover, Il4−/− mice showed a significantly earlier onset of tumor 
development, a greater incidence of tumors and larger tumors than 
that of wild-type mice following weekly treatment with DMBA 
(Fig. 4c), which indicated that IL-4 was required for protection 
against tumors. Tumor-bearing Il4−/− mice did not produce IgE and 
had diminished production of IgG1, but greater production of IgG2a, 
in serum than that of their wild-type counterparts (Supplementary 
Fig. 2c). Thus, α β T cell–derived IL-4 was critical for IgE production 
and protection against tumors following exposure to DMBA.
Induction of tumor-protective IgE requires γδTCR+ IELs. Skin γ δ 
TCR+ IELs are key for protective immunity to chemical carcinogen-
esis and are strong inducers of local type 2 immune responses11–13. 
We found that following topical exposure of the ear skin to DMBA, 
Tcrd−/− mice, which lack γ δ T cells, had less LN hypertrophy than 
that of wild-type mice but had a normal number of GC B cells 
(Fig. 5a). Tcrd−/− mice developed IgG1+ PCs similar to the develop-
ment of such cells in wild-type mice but had significantly impaired 
IgE PC responses compared with those of wild-type mice (Fig. 5a). 
The decrease in IgE was detected as early as day 4, a time at which the 
number of IgE+ PCs and serum IgE had increased in wild-type mice 
but remained undetectable in Tcrd−/− mice (Fig. 5a,b). GCs were not 
yet enlarged in wild-type mice at day 4 (Fig. 5a), which suggested 
that the γ δ T cell–dependent IgE response at this time might have 
been of extrafollicular origin. To explore this, we used CD19creBcl6fl/fl 
mice, which have a B cell–specific defect in the transcription factor 
Bcl-6. CD19creBcl6fl/fl mice did not develop a GC response follow-
ing topical application of DMBA, despite LN enlargement, but the 
number of IgE+ and IgG1+ PCs in their LNs was equivalent to that in 
the LNs of their Bcl6-heterozygous littermates and wild-type mice 
(Supplementary Fig. 5d).
We next sought to determine whether the γ δ T cells involved 
in the response were located in the skin itself or in a secondary 
lymphoid organ such as the draining-LNs. Skin-resident γ δ TCR+ 
IELs are radiation resistant11, and in Tcrd−/−→ WT bone-marrow 
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Fig. 3 | Carcinogen-induced IgE provides protection against carcinogenesis. a,b, Tumor susceptibility in wild-type (WT) and Igh7−/− BALB/c mice (n =  14 
per group) (a) and wild-type (n =  10) and Fcer1a−/− (n =  11) BALB/c mice (b) (key) at various times (horizontal axis) after DMBA-induced carcinogenesis, 
presented as tumor latency (time to appearance of first tumor; presented as the frequency of tumor-free mice), tumor incidence (average tumors per 
mouse) and tumor area (average size per mouse). P values (in plots), log-rank (Mantel-Cox) test for tumor latency, and linear regression for tumor 
incidence and area. Data are representative of two independent experiments with similar results (mean ±  s.e.m., middle and right). c, Frequency of Fcε RI+ 
cells among total CD45+ leukocyte infiltrates in human SSC tissue (n =  12 donors), peri-lesional skin (n =  10 donors) and blood samples (each paired with 
the same tissue and skin donor; n =  10 donors) (horizontal axis), assessed by flow cytometry; red triangles, mean proportion of Fcε RI+ cells in the group; 
lines connect results for samples from the same donor. **P <  0.01 (paired Wilcoxon test). d, Expression of FCER1A transcripts in human skin and SSC tissue 
from individual ‘risk groups’ (assigned scores independently for ‘tumor risk’ by an experienced dermatopathologist), in unaffected areas (Non-UV; n =  3 
donors) and peri-lesional tissue (n =  6 donors), and from patients with low-risk SSC =  (n =  12 donors) or high-risk SSC (n =  24 donors) and metastatic SSC 
(n =  11 donors), assessed with an NanoString nCounter and presented as log2 values of RNA counts. Each symbol represents an individual donor; small 
horizontal lines indicate the mean ( ±  s.e.m.). P value, one-way ANOVA and testing for linear trend of expression between ‘risk groups’.
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chimeras or WT→ Tcrd−/− bone-marrow chimeras, γ δ T cells 
were detected only in the skin or LNs, respectively (Fig. 5c). 
When these chimeras were treated topically with DMBA, IgE was 
significantly reduced only in WT→ Tcrd−/− chimeras, in which γ δ 
TCR+ IELs were missing from the skin, but γ δ T cells were pres-
ent in the LNs, compared with the IgE in WT→ WT chimeras 
(Fig. 5d). The number of IgG1+ PCs was similar in Tcrd−/−→ WT, 
WT→ Tcrd−/−, WT→ WT and Tcrd–/–→ Tcrd–/– chimeras (Fig. 5d). 
The abundance of Vγ4+ and other ‘non-Vγ5+’ γ δ T cells in the 
skin of Tcrd−/−→ WT and WT→ Tcrd−/− chimeras was similar to 
that in the skin of WT→ WT chimeras (Fig. 5c). In addition, fol-
lowing topical treatment with DMBA, Tcrg-V5–/–Tcrd-V1–/– mice, 
which lack only the canonical Vγ5 Vδ1+ IELs, had fewer IgE+ PCs 
than did wild-type mice (Fig. 5e), which suggested that Vγ5+ 
IELs were most probably the IgE-promoting γ δ T cell subset. 
These observations indicated that DMBA-induced IgE depended 
on γ δ TCR+ IELs in the tissue.
γδ T cells promote a distinct IgE repertoire in response to a 
carcinogen. To understand the nature of the humoral response 
produced during epithelial-cell damage, and the role of γ δ T cell 
immunosurveillance, we sorted B220+CD95+GL7+ GC B cells and 
FSChiCD95hiCD138+ PCs from the skin draining LNs of wild-type 
and Tcrd−/− mice 7 d after the second of two topical exposures to 
DMBA. Analysis of the IgG1 and IgE heavy-chain repertoires by 
high-throughput sequencing revealed that IgE-producing clones 
had the largest clonal expansion in wild-type mice (Supplementary 
Fig. 6a). As expected, the average size for IgG1+ clones was greater 
among PCs than among GC B cells (Fig. 6a). In contrast, IgE+ clones 
among PCs and GC B cells were equivalent and were larger than 
IgG1+ clones (Fig. 6a). Furthermore, Tcrd−/− mice had defective 
IgE+ clonal expansion in GC B cells compared with that of wild-
type mice, while IgG1+ clonal expansion was similar (Fig. 6b). 
The Alakazam tool17, an analysis framework for the sequencing of 
adaptive immunoreceptor repertoires, indicated that the IgE+ PC 
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repertoire was significantly less diverse in Tcrd−/− mice than in wild-
type mice in all but the most common clones (Fig. 6c). In contrast, 
the diversity of the IgG1+ PC repertoire in Tcrd−/− mice was similar 
to that of wild-type mice (Fig. 6c).
We also analyzed the physicochemical properties of the comple-
mentarity-determining CDRH3 regions by principal-component 
analysis (PCA) of Kidera factors18, which are a set of independent 
factors that encapsulate information from 188 different biophysical 
characteristics of all 20 amino acids. We observed distinct differ-
ences between GC B cells and PCs, as well as between IgG1-switched 
clones and IgE-switched clones in wild-type mice, in the biophysical 
characteristics of CDRH3 protein (Fig. 6d), which indicated that the 
majority of IgE+ PC clones were of extrafollicular origin and had 
switched directly from IgM to IgE. That conclusion was supported 
by clonal analysis, which indicated that < 30% of IgE+ PC clones 
were shared with IgG1+ PC clones and only around 30% of IgE+ PC 
clones were shared with IgE+ GC clones (Supplementary Fig. 6b,c). 
Furthermore, Kidera PCA showed that the properties of IgE and 
IgG1 in Tcrd−/− mice were different from those of IgE and IgG1 in 
wild-type mice (Fig. 6d), which suggested that immunosurveillance 
by γ δ T cells had a role in selecting the physiochemical properties of 
the CDRH3 regions.
Selection events are also expected to shape the B cell repertoire in 
terms of the use of genes encoding the variable, diversity and join-
ing (VDJ) regions of the immunoglobulin heavy chain. We found 
that only five main genes of the Igh-V family and five main genes of 
the Igh-D family were commonly used, but all four Igh-J genes were 
used, by both IgG1+ and IgE+ GC B cells and PCs (Supplementary 
Fig. 6d–f). The third-most-frequent D region–encoding gene in 
IgE+ and IgG1+ GC B cells and PCs could not be annotated by the 
Immunogenetics (IMGT) information system, most probably due 
to an Igh-D gene in the genome of the FVB mouse strain that is 
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absent from the IMGT genomic data, as the heavy-chain repertoire 
is highly variable among inbred strains19. We annotated this newly 
identified gene as ‘Dx’. Three-dimensional analysis of VDJ use in 
IgE+ PCs indicated that V1D2 was the dominant selection (Fig. 6e), 
consistent with data showing that the immunoglobulin heavy-
chain V1 family is most frequently used in mouse immunoglobu-
lins19,20. J-region usage was approximately equal among the four 
J-region family groups (Fig. 6e). The VDJ analysis also revealed 
that some VDJ combinations in wild-type mice, particularly the 
newly identified ‘V3Dx’ segment, were significantly less selected 
in IgE+ PCs from Tcrd−/− mice than in those from wild-type 
mice (Fig. 6e–g).
We next compared the physicochemical properties of CDRH3 
in the wild-type V3Dx+ clones with those of V3D2+ clones, which 
used the same V region–encoding gene but a different D region–
encoding gene, V1D2+ clones, which were the most common selec-
tion, and V14D2+ clones, which did not require γ δ T cell selection. 
Kidera-factor PCA indicated that the V3Dx+ clones had unique 
physicochemical characteristics of their CDRH3 (Fig. 6h) and had 
a lower frequency of aromatic and small amino acids, but a higher 
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frequency of aliphatic and basic amino acids, as well as a higher isoelec-
tric point than that of clones of the other VD combinations (Fig. 6i). 
These characteristics suggested that the antigen-binding site was 
hydrophobic, with slight positive charge in the loop at blood pH. In 
addition, the V3Dx-expressing clones had shorter CDRH3 regions 
than those of the V1D2+ or V3D2+ clones (Fig. 6i), indicative of 
antigen selection21,22, and carried fewer mutations (Fig. 6j), which 
indicated that they were more germline in nature. In sum, these data 
indicated that in response to DMBA, γ δ TCR+ T cells shaped the 
IgE repertoire by supporting specific VDJ rearrangements, which 
resulted in unique characteristics of the CDRH3 antigen-binding 
site, suggestive of polyreactive autologous binding.
DMBA-induced IgE is autoantigenic and differs from TPA-
induced IgE. We next explored whether the IgE responses induced 
by topical DMBA were autoreactive. We screened the binding of 
IgE from the serum of DMBA-treated wild-type mice to human 
HEp2 epithelial cells and observed several strong staining patterns 
(Fig. 7a and Supplementary Fig. 7a) indicative of both autoreactivity 
of IgE and cross-species reactivity of IgE. The most common stain-
ing patterns of IgE on HEp2 cells were ‘nuclear dots’, indicative of 
anti-nuclear specificity, and ‘cytoplasmic vesicles’ that resembled 
stress granules (Fig. 7a and Supplementary Fig. 7a). In addition, we 
detected IgE reactivity to dsDNA (Fig. 7b) and to damaged epithelial 
cells, frequently around hair follicles, in epidermal sheets isolated 
from Fcer1a−/− mice 24 h after exposure to DMBA (Supplementary 
Fig. 7f–g). We detected no autoreactivity to HEp2 cells for IgE from 
the serum of DMBA-treated Tcrd−/− mice or IgE from the serum 
of wild-type mice treated topically with the inflammatory chemi-
cal TPA (12-O-tetradecanoylphorbol-13-acetate) (Fig. 7a and 
Supplementary Fig. 7b,c), which did not elicit DNA damage in epi-
thelial cells (Fig. 7c), but triggers general skin inflammation.
We next sorted FSChiCD95hiCD138+ PCs from the skin-drain-
ing LNs of wild-type mice exposed topically to DMBA or TPA and 
compared their IgE heavy-chain repertoires by high-throughput 
sequencing. Alakazam analysis indicated that TPA-induced IgE+ 
PCs exhibited significantly less diversity throughout the rep-
ertoire than that of DMBA-induced IgE+ PCs (Fig. 7d). Kidera-
factor PCA indicated more heterogeneity in the CDRH3 regions 
of TPA-induced IgE than in those of DMBA-induced IgE, with 
little overlap between the two responses (Fig. 7e). In parallel, 
use of VDJ-encoding gene families among TPA-induced IgE was 
dominated by V1-encoding genes, with significantly less selection 
for V3-encoding genes and V14-encoding genes than that among 
DMBA-induced IgE (Fig. 7f,g). Notably, TPA also did not gener-
ate the V3Dx-expressing clones, which we had found to be pro-
moted by γ δ T cells in response to DMBA-induced DNA damage 
(Fig. 7g). Together these results indicated that exposure of the skin 
to DMBA drove a unique, autoreactive IgE repertoire that was dis-
tinct from that induced in response to TPA, which induced local 
acute inflammation.
Discussion
Here we found that IgE was rapidly induced by cutaneous expo-
sure to the carcinogen DMBA and accumulated in the skin and 
tumors on Fcε RI-expressing basophils. The IgE response required 
γ δ TCR+ IELs, was autoreactive and was protective against epithe-
lial carcinogenesis. Fcε RI-expressing cells also accumulated in 
human skin SCCs, and the level of Fcε RI expression correlated 
with disease severity. Together our data indicated that IgE contrib-
uted to early tissue immunosurveillance against environmental 
xenobiotics or toxins and had a role in protection against epithelial 
tumor development.
Polyaromatic hydrocarbons such as DMBA are ubiquitous and 
arise from many sources, including car emissions and tobacco 
smoke14,15. They are the main organic constituent in air pollution, 
and their levels correlate with the prevalence and severity of atopic 
dermatitis23,24. In mice, chronic exposure of the skin to air pollut-
ants can induce atopic dermatitis–like features and IgE production. 
However, while gene expression in the skin depends on ligation of 
the aromatic hydrocarbon receptor by polyaromatic hydrocarbons, 
the increase in IgE does not25. Consistent with that, we found that 
the initiation of IgE induction after topical application of DMBA 
depended on epithelial DNA damage, not direct engagement of the 
aromatic hydrocarbon receptor. Host DNA can selectively induce 
IgE26, which would suggest that dying cells have unique IgE-adjuvant 
activity. Furthermore, expression of autologous stress antigens, such 
as NKG2D ligands, on damaged skin epithelia promotes IgE pro-
duction12. Topical application of TPA also induces the expression of 
NKG2D ligands27, which might partly explain the induction of IgE 
by this agent. However, sequencing analysis revealed that different 
types of tissue damage initiated distinct IgE repertoires. In humans, 
self-reactive IgE has been found in patients with systemic lupus ery-
thematous28,29, bullous pemphigoid30, atopic dermatitis31 or primary 
immune deficiencies32. Such data suggest that IgE responses are 
potently promoted by autologous cell stress and/or damage, which 
is induced by exposure of the skin to environmental xenobiotics.
IELs provide a first line of defense in epithelial tissues. A large 
proportion of IELs carry γ δ TCRs and are autoreactive in nature, 
as they express receptors for tissue-specific stress molecules33. We 
found that following DMBA-induced epithelial damage, IELs rap-
idly elicited IgE in the parafollicular regions and subsequently trig-
gered a conventional adaptive response that required polyclonal α β 
TCR+ CD4+ T cells that produced IL-4. This mode of inducing IgE 
differs from the regulation of self-reactive ‘natural IgE’, which is also 
driven by γ δ T cells but is independent of α β T cells and major his-
tocompatibility complex class II34,35. Deep sequencing of IgG1+ and 
IgE+ GC B cells and PCs demonstrated that γ δ T cells shaped the 
repertoire and the nature of the antibodies produced. Thus, anti-
body deep sequencing revealed a previously unrecognized mode of 
B cell selection dictated by tissue-resident IELs.
γ δ T cells and tissue-specific γ δ IELs are key participants in host 
defense against cancer, which is considered to reflect innate prop-
erties such as cytotoxicity and cytokine production11,13,27. Here we 
found that they were able to provide a second line of host defense 
via the initiation of adaptive autoreactive IgE responses and Fcε 
RI-expressing effector cells. Our findings that endogenous IgE 
was able to suppress tumor growth are supported by evidence 
that immunization with tumor-antigen-specific IgE can eradicate 
tumors and is more effective than immunization with IgG136,37. How 
IgE inhibited tumor growth in our model remains to be determined; 
however, it required expression of Fcε RI, and mast cells were not 
essential, which would suggest it might involve soluble factors and/
or cytotoxicity mediated by basophils.
In humans, epithelial skin cancers are on the rise38,39. In addition 
to UV irradiation, environmental chemical carcinogens can also lead 
to the development of skin SCC, as indicated by the causal link, in 
chimney sweeps, between scrotal SCC and exposure to soot, which 
contains polyaromatic hydrocarbons40. Moreover, tobacco smokers, 
who are exposed to large amounts of polyaromatic benz[a]antracene, 
have a 50% increased likelihood of developing skin SCC41. Studies of 
IgE and cancer risk in humans have shown a negative, albeit weak, 
correlation between serum IgE and overall cancer risk42,43. In addi-
tion, FCER1A is reported to be among the top 50 genes associated 
with positive survival in 39 human malignancies44. The presence of 
intratumoral γ δ T cells is the most favorable prognostic indicator 
of survival in patients with cancer44, while a large number of infil-
trating PCs is also strongly associated with good clinical outcome44. 
Consistent with those observations, we found that Fcε RI-expressing 
cells were abundant in human SCC, and there was an inverse corre-
lation between expression of FCER1A and more-advanced disease. 
Of note, the use of omalizumab, a monoclonal antibody that blocks 
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IgE, has been associated with more-frequent development of cancer, 
particularly epithelial and solid-organ cancers45.
Together these findings suggest that the IgE–Fcε RI axis is part 
of a tumor-protective immune response and provide support for 
the ‘toxin hypothesis’, which proposes that IgE is a host defense 
mechanism against non-infectious cell-damaging environmental 
xenobiotics.
Methods
Methods, including statements of data availability and any asso-
ciated accession codes and references, are available at https://doi.
org/10.1038/s41590-018-0161-8.
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Methods
Mice. Genetically altered mice were generated as previously described. Tcrd−/− 
mice46, Tcrb−/− mice47, Il4−/− mice48, Langerin-DTA (LC-deficient) mice49 and  
Tcrg-V5–/–Tcrd-V1−/− mice50,51 were on the FVB/N background after > 10 backcrosses; 
Igh-7−/− mice52, Fcer1a−/− mice53 and Cpa3Cre/+ mice54 were on the BALB/c 
background after more than ten backcrosses; and OT-II Tg mice55, Tcrb−/− mice47, 
CD19-Cre mice56 and Bcl6fl/fl mice57 were on the C57BL/6 background. Strain-
matched wild-type control mice were purchased from Charles River. Mice were 
bred and maintained in individually ventilated cages under specific pathogen-free 
conditions. Age-matched female mice were used for all experiments at ≥ 7 weeks of 
age and were selected at random from a large pool when allocated to experiments. 
All studies were approved by Imperial College AWERB (Animal Welfare and 
Ethical Review Body) and by the UK Home Office. Experiments involving cancer 
studies strictly adhered to the guidelines set out by the National Cancer Research 
Institute (NCRI) and in the document ‘Guidelines for the Welfare and Use of 
Animals in Cancer Research’58. All studies using animals were conducted following 
the document Animal Research: Reporting In vivo Experiments (ARRIVE)59.
Chemical cutaneous damage and carcinogenesis. Chemicals 
7,12-dimethylbenz[a]anthracene (DMBA) and 12-0-tetradecanoylphorbol-13-
acetate (TPA) were purchased from Sigma and were dissolved in acetone and 
100% ethanol, respectively. Acute damage was induced by exposure of the dorsal 
sides of the ear skin to a single dose or repeated doses of 200 nM DMBA or 2.5 nM 
of TPA, in 25 μ l.
For cutaneous carcinogenesis, age-matched female mice were used at 7 weeks 
of age. The dorsal back area was shaved with a surgical blade and mice were 
allowed to ‘rest’ for 1 week. Applications of chemicals and tumor monitoring were 
performed as previously described13. In brief, 200 nM DMBA was carefully and 
slowly applied by pipette, in a 100-μ l volume, to the entire shaved skin area. Mice 
were allowed to ‘rest’ for 1 week, and 100 nM DMBA was then applied weekly. Hair 
regrowth during the experiment was gently removed by clipping with trimmers. 
Mice were monitored daily, and cutaneous tumors were counted and measured 
with a caliper once weekly. Back skin and tumors were evaluated by visual 
inspection by an observer blinded to the experimental groups.
UV irradiation. The back skin of FVB mice was shaved using electrical clippers 
3 d before UV irradiation. Mice were exposed to the UV light source in their 
cages placed under four 100-W UV lamps with the spectral output 270–350 nm 
(predominantly UVB) (Philips TL12 lamps). The total dose of UVB radiation 
was monitored during each exposure using an IL-400 A UVB photometer 
(International Light). Mice were given 100 mJ/cm2 three times a week.
Tissue processing. Tissue was cut into small 1-mm2 pieces using a scalpel 
blade and incubated for 2 h in digestion buffer containing 25 μ g/ml Liberase 
(Roche), 250 μ g/ml DNAseI (Roche) and 1 × DNAse buffer (1.21 Tris base, 0.5 g 
MgCl2 and 0.073 g CaCl2) at 37°. Following digestion, tissue was transferred 
into C-tubes (Miltenyi Biotech) containing RPMI-1640 medium (Thermo 
Fisher) supplemented with 10% heat-inactivated fetal calf serum, 1% penicillin-
streptomycin-glutamine (Thermo Fisher) and was physically disrupted using 
a Miltenyi cell dissociator. Cell suspensions were then filtered and cells were 
counted using a CASY cell counter (Roche).
Flow cytometry. Cell suspensions were blocked for non-specific binding using 
antibody to Fcγ R (2.4G2, BD) and 2% normal rat serum (Sigma) before any 
staining protocols. For staining of cell-surface markers, cell suspensions were 
stained with fluorochrome-conjugated antibodies or the appropriate isotype-
matched control antibody with the addition of a fixable, live/dead discrimination 
dye (Invitrogen) for 25 min and were subsequently washed. Intracellular 
staining was then carried out using an Intracellular Staining kit according to the 
manufacturer’s instructions (ThermoFisher Scientific). Cells were fixed for 10 min 
at 4 °C, washed with Perm buffer and stained for intracellular markers for 25 min. 
For intranuclear staining of γ H2AX, cells were fixed and permeablized in ice-cold 
70% ethanol at –20 °C for 2 h, blocked with 2% normal mouse serum (Sigma), Fc-
block and 2% FCS for 15 min, followed by 45 min of staining for γ H2AX at room 
temperature. Stained cells were analyzed using a BD FACSVerse and a Fortessa X20 
(BD Biosciences). Data analysis was performed using FlowJo 10 for Mac (TreeStar).
Antibodies were sourced from eBioscience unless otherwise stated. The 
following antibodies were used: anti-CD45 (30-F11), anti-B220 (RA3-6B2), 
anti-CD38 (90/CD38, BD), anti-CD138 (281-2, BD), anti-CD95 (Jo2), 
anti-GL7 (GL-7), anti-CD3 (145-2C11, Biolegend), anti-IgE (23G3), anti-IgG1 
(M1-14D12), anti-IgG2a (R19-15, BD), anti-TCRβ (H57-597), anti-TCRγ δ 
(eBioGL3), anti-Vγ5 (536), anti-Vγ4 (UC3-10Ab, Biolegend), anti-CD117 (2B8), 
anti-CD41 (MWReg30, Biolegend), anti-Fcε RI (MAR-1, Biolegend), anti-IL-4 
(11B11), anti-IL-6 (MP5-20F3, Biolegend), anti-CD63 (NVG-2, Biolegend) and 
anti-γ H2AX (JBW301, Millipore).
ELISA. For IgG1 and IgG2a antibodies, NUNC Immune Maxisorp 96-well plates 
(Thermo Scientific) were coated with 5 μ g/ml goat anti-mouse IgH + L (1010-01, 
Southern Biotech) in borate-buffered saline at 37 °C for 3 h. After washing, plates 
were blocked with PBS containing 0.5% BSA for 1 h at room temperature and the 
appropriately diluted serum was added, followed by incubation overnight at 4 °C.  
After washing, plates were incubated with alkaline phosphatase–conjugated 
polyclonal goat anti-mouse IgG1 (1070-04) or IgG2a (1080-04) (also detects 
IgG2c in C57BL/6 mice) (both from Southern Biotech) for 5 h at 4 °C. Following 
further washing, the alkaline-phosphatase substrate pNPP (Sigma) was added and 
absorbance was measured at 405 nm. Total IgE was measured by an IgE-capture 
method. Serum to be tested and the IgE standard were added to plate wells coated 
with 1 μ g/ml rat monoclonal antibody to mouse IgE (R35-92, PharMingen) and 
blocked with 1% rat serum. Biotinylated rat monoclonal antibody to mouse IgE 
(R35-92, PharMingen) at 1 μ g/ml was then added, followed by incubation for 2 h at 
37 °C. After washing in PBS plus 0.05% Tween, plates were incubated with alkaline 
phosphatase–conjugated streptavidin (PharMingen) for 1 h at 37 °C. After washing, 
detection of antibody levels was carried out by addition of the alkaline-phosphatase 
substrate pNPP (Sigma) and absorbance was measured at 405 nm.
For analysis of IgE autoreactivity to dsDNA, MaxiSorp plates were coated 
with 1 μ g/ml rat monoclonal antibody to mouse IgE (R35-92, PharMingen) and 
were blocked with 1% rat serum and 3% milk. Serum samples were screened at 
1:25 dilution. 100 ng/ml biotinylated herring sperm dsDNA (Promega) was then 
added, followed by incubation overnight at 4 °C. After washing in PBS plus 0.05% 
Tween, plates were incubated with alkaline phosphatase–conjugated streptavidin 
(PharMingen) for 1 h at 37 °C. After washing, detection was carried out by addition 
of the alkaline-phosphatase substrate pNPP (Sigma) and absorbance was measured 
at 405 nm. Autoantibody levels are presented in arbitrary ELISA units.
HEp-2 staining. Autoreactivity of IgE was tested by indirect immunofluorescence 
using HEp-2 cells. Serum samples were diluted appropriately (tested in dilutions 
between ‘neat’ and 1:25, depending on IgE titers) and were incubated on HEp-2 
slides (Bio-Rad) overnight at 4 °C. After washing in PBS, slides were incubated 
with purified rat anti-mouse IgE (R35-92, PharMingen) for 2 h, then were 
washed again and further incubated with the secondary antibody anti-rat 555 
(A21434, ThermoFisher) for 1 h at room temperature. As a control, serum from 
similarly treated IgE-deficient mice was also assessed, as well as serum from naive 
wild-type mice. Slides were thoroughly washed and mounted with Vectashield 
containing DAPI (Vectashield) and were visualized with a Leica DM4 fluorescence 
microscope (Leica).
Immunofluorescent staining of tumor samples. Tumors were removed from the 
back along with a small piece of adjacent skin and were snap-frozen in OCT on 
dry ice. 6-μ m sections were cut using a Leica JUNG CM1800 cryostat and were 
stored at –80 °C. For staining, slides were returned to room temperature before 
fixation with 4% paraformaldhyde for 15 min. Samples were then blocked in 
5% goat serum for 1 h at room temperature before staining with rat anti-mouse 
IgE (R35-92, PharMingen) overnight at 4 °C. Following staining, samples were 
washed and incubated with Alexa Fuor 555–conjugated goat anti-rat IgG (A21434, 
ThermoFisher). After extensive washing, samples were mounted in VectaShield 
containing DAPI (Vectashield) and were visualized with a Leica SP5 confocal laser-
scanning microscope (Leica).
Epidermal sheets. Ears were collected, split into dorsal and ventral sides and 
floated dermis side down in 0.5 M NH4SCN for 40 min, 37 °C and 5% v/v CO2. 
Subsequently, intact epidermal sheets were isolated and washed in PBS. They 
were then fixed in ice-cold acetone at –20 °C for 15 min, followed by rehydration 
in PBS. Nonspecific binding to the epidermal tissue was blocked with 2% BSA 
for 1 h, and then 1:25 dilution of test serum was added, followed by incubation 
overnight at 4 °C. Any IgE binding to the tissue was visualized by first incubating 
with rat anti-mouse IgE (R35-92, BD) followed by Alexa Fluor 555–conjugated 
goat anti-rat IgE (A21434, ThermoFisher), each for 1 h at room temperature. 
After extensive washing in PBS, samples were mounted in VectaShield containing 
DAPI (Vectashield) and were visualized with a Leica SP5 confocal laser-scanning 
microscope (Leica).
Adoptive-transfer experiments. Whole CD4+ T cells were isolated from the spleen 
of donor wild-type and Il4−/− mice (using Miltenyi MACS isolation kits). For 
OT-II transfer experiments, OT-II CD4+ T cells were cell sorted using ovalbumin 
peptide–loaded tetramers (NIH Tetramer Facility). 2 × 106 cells were injected 
intravenously, mice were allowed to ‘rest’ for 24 h, and the dorsal ear skin was then 
exposed to DMBA as described above.
Bone-marrow chimeras. Wild-type, Tcrd−/− and Il4−/− mice were sublethally 
irradiated (750 rads) and immediately reconstituted with 5 × 106 donor bone-
marrow cells by intravenous injection. Mice were left for 8 weeks for fully 
reconstitution with the hematopoietic cells, and then they were exposed to DMBA 
on the skin as described above. Chimerism was assessed by flow-cytometry 
analysis of peripheral LNs and skin tissue at the end of the experiments.
qRT-PCR and primer sequences. RNA was extracted from ammonium-fixed 
epidermis or tumor tissue and preserved in RNA-later with an RNEasy Mini kit 
(Qiagen). RNA was dissolved in nuclease-free water, and yield and purity  
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were determined. Complementary DNA (cDNA) was synthesized from RNA  
with an iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer’s 
instructions. cDNA was diluted in nuclease-free double-deionized water  
for qRT-PCR. All primers were single-stranded DNA oligonucleotides  
(Sigma) that were intron spanning as verified by NCBI Primer-Blast tool.  
Real-time PCR products were detected with SYBR Green (Life) measured  
continuously with a ViiA 7 Real-Time PCR system (Applied Biosystems).  
Ct values for genes of interest were normalized against Ct values of the  
housekeeping gene encoding cyclophilin (Cyc) using the 2–ΔCt method. The  
following primers were used: IgE, F (5′ -CAAGTCAGCCAAGAACTTCAC-3′ )  
and R (5′ -GACAGGTCGAACTAGGATAGTC-3′ );  
IgG1, F (5′ -TTGCATATGTACAGTCCCAG-3′ )  
and R (5′ -GTCAGAGTAATGGTGAGCAC-3′ );  
IgM, F (5′ -AAGACTGGAATAACAGGAAGGA-3′ )  
and R (5′ -GTTTGTGCACCTCATTGGG-3′ ); Rae1, F  
(5′ -TGGACACTCACAAGACCAATG-3′ ) and R  
(5′ -CCCAGGTGGCACTAGGAGT-3′ ); IL-4, F (5′ -CATCGGCATTTTGAACGAG-3′ ) 
and R (5′ -CGAGCTCACTCTCTGTGGTG-3′ );  
IL-6, F (5′ -TGATGGATGCTACCAAACTGG-3′ )  
and R (5′ -TTCATGTACTCCAGGTAGCTATGG-3′ );  
IL-33, F (5′ -CACATTGAGCATCCAAGGAA-3′ )  
and R (5′ -AACAGATTGGTCATTGTATGTACTCAG-3′ );  
and Cyc, F (5′ -CAAATGCTGGACCAAACACAA-3′ ) and R  
(5′ -CCATCCAGCCATTCAGTCTTG-3′ ).
Immunoglobulin sequencing and analysis. Mice were treated twice with  
DMBA or TPA to the dorsal side of the ear skin, 3 d apart. 1 week after the  
final exposure, draining LNs were collected and GC B cells (B220+CD95+GL7+) 
and PCs (FSChiCD95hiCD138+) were sorted on a BD FACSAria III  
(BD Biosciences). RNA was extracted using RNEasy Micro kits (Qiagen)  
and was reverse transcribed using SuperScript III Reverse Transcriptase 
(ThermoFisher). Sequences were amplified using Phusion High-Fidelity  
DNA Polymerase (NewEngland Biolabs) to ensure accuracy and robust 
performance for large PCR products. PCR was performed with a primer  
in the constant Cε region (5′ -CTAGGGTCATGGAAGCAGTGCC-3′ ) or Cγ1 
region (5′ -GGGAAATAGCCCTTGACCAGG-3′ ) in combination with a 
promiscuous V-region primer (binding all V-region heavy-chain genes)  
(5′ -GAGGTGCAGCTGCAGGAGTCTGG-3′ ). All primers were labeled at either 
end with multiplex identifiersfor multiplexing. PCR thermal cycling was as 
follows: 98 °C, 30 s; 30 × (98 °C, 30 s; 60 °C, 30 s; 72 °C, 35 s); and 72 °C, 10 min. 
Amplicons were purified by gel extraction using a QIAquick PCR purification 
kit (Qiagen) and were deep sequenced by long-read 454 pyrosequencing on the 
Genome Sequencer FLX system (Roche). Raw sequencing data were presented 
in.FASTA format and unproductive sequences were removed (data cleanup stages 
as described60).
Analysis was performed as previously described60. In brief, sequences were 
assigned to individual samples according to their multiplex identifier. V(D)
J gene assignment of individual sequences were annotated using IMGT/HighV-
Quest and the mouse database. Mean values of V(D)J gene usage were calculated 
before three-dimensional bubble plots were created using the R package plot3D. 
Repertoire diversity was characterized using the Hill diversity index61,62 and were 
plotted using the Alakazam package17. Physiochemical properties of the CDRH3 
region were calculated using the R package Peptides. Physiochemical properties 
included length, isoelectric point (pI), frequency of amino acid classes in the 
CDRH3 region, and Kidera factors. Kidera factors are a set of ten independent 
factors that encapsulate information from ~180 different measurable biophysical 
characteristics of all 20 amino acids18. Principal component analysis of Kidera 
factors was performed using the prcomp function in R using Minkowski distances 
as previously described63.
Human tissue. For flow cytometry, freshly excised SCC tissue and peripheral 
blood were obtained from 12 patients during surgery at the Dermatology 
Department of University Hospital Southampton NHS Foundation Trust. Ethics 
were provided by the South Central Hampshire B NRES Committee (reference 
number 07/H0504/187). All participants recruited to the study provided informed 
consent for blood and tissue samples to be used for research purposes. All tumor 
tissue used in the study was confirmed SSC with a diameter of > 8 mm. Non-
lesional skin was histopathologically normal and > 6 mm away from the tumor 
edge. To obtain single-cell suspensions, tumor samples were cut into small pieces 
and enzymatically digested with 1 mg/ml collagenase I-A (Sigma) and 10 µ g/ml 
DNAse I (Sigma) in RPMI medium at 37 °C for 1.5 h. The resulting suspension 
was passed through 70-µ m cell strainers and centrifuged in Optiprep (Axis-
Shield). PBMCs were isolated from venous blood from the patients with SCC 
by centrifugation with Lymphoprep (Axis-Shield). Single cell suspensions were 
stained for flow cytometry with antibody to CD45 (2D1) and antibody to Fcε R1 
(MHE-18) (both from BioLegend). Cells were gated on FSC and SSC and dead cells 
were excluded using near IR live/dead stain (Invitrogen).
For immunohistochemistry analysis of human SSC tissue, 5-µ m tissue sections 
were cut from formalin-fixed paraffin-embedded samples and were placed 
onto 3-aminopropyltriethoxysilane (APES)-coated microscope slides. Sections 
were deparaffinized in xylene and were rehydrated through graded alcohols. 
Endogenous peroxidase was inhibited with 0.5% hydrogen peroxide before antigen 
retrieval by microwaving in 10 mM citrate buffer, pH 6. Endogenous avidin and 
biotin were blocked (Vector Labs) before the application of Dulbecco’s Modified 
Eagle’s Medium (Gibco) containing 1% bovine serum albumin (Sigma) and 20% 
fetal bovine serum (Gibco) blocking medium. Primary antibody to FcER1 (9E1, 
1:20 dilution (Abcam)) was then left on the sections for 16 h at 4 °C before three 
washes with Tris-buffered saline (TBS), followed by application of biotinylated 
goat anti-mouse (1:400 dilution; 115-065-003, Jackson ImmunoResearch) for 
30 min. After three washes with TBS, streptavidin–biotin complexes (Vector Labs) 
were applied, before three washes with TBS and application of diaminobenzidine 
(DAKO). After washing with TBS, sections were counterstained with Mayer’s 
Hematoxylin (Sigma) and were dehydrated through graded alcohol and xylene. 
Sections were mounted in DPX mountant (Sigma) and coverslips were applied. 
Slides were imaged at × 2 and × 20 magnification using an Olympus Dotslide 
microscope and were analyzed using OlyVIA software.
For gene expression in SSC tumors, fixed frozen paraffin-embedded 
skin samples were analyzed from 56 patients obtained from the University 
of Dundee, Tayside NHS Trust and Greater Glasgow and Clyde NHS Trust. 
The study was conducted according to the Declaration of Helsinki Principles, 
and all patients donating samples to this study provided written, informed 
consent in accordance with ethical approval from the East of Scotland Research 
Ethics Service (EoSRES) REC 1. SSC tumors were graded by an experienced 
dermatopathologist as low risk or high risk based on the Scottish Intercollegiate 
Guidelines Network for cutaneous SCC. In addition, peri-lesional skin 
(histopathologically normal looking skin > 4 mm away from the tumor edge) 
and abdominal non-UV-exposed skin were also analyzed. Total RNA was 
extracted using a Qiagen RNeasy extraction kit and was directly hybridized 
using the NanoString PanCancer and PanCancer Immune expression panel and 
analyzed on an nCounter (NanoString).
Statistical evaluation. The statistical significance of difference between 
experimental groups was determined using two-tailed Student’s t-test for  
unpaired data, Wilcoxon test for paired samples, one-way ANOVA or linear 
regression, where appropriate, with results deemed significant at P < 0.05.  
Asterisk significance correlates as follows: *P < 0.05; **P < 0.01; ***P < 0.001;  
and ****P < 0.0001. Statistics were analyzed with GraphPad Prism 6.00 for  
Mac (GraphPad).
Reporting Summary. Further information on experimental design is available in 
the Nature Research Reporting Summary linked to this article.
Data availability statement. The data supporting the findings of this study are 
available from the corresponding author upon request. RNA sequencing data are 
available from the public repository on the National Center for Biotechnology 
Information’s Sequence Read Archive in raw format (accession codes: BioProject, 
PRJNA417372; BioSample, SAMN07985450, SAMN07985451, SAMN07985452, 
SAMN07985453, SAMN07985454 and SAMN07985455).
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in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main 
text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND 
variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Clearly defined error bars 
State explicitly what error bars represent (e.g. SD, SE, CI)
Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection BD FACS Diva software version 8.0.1, Quant Studio RT-PCR version 1.3, ELISA Ascents software version 2.6.
Data analysis All software used throughout this work is publicly available: FlowJoV8.8.7/10, ImageJ, Graph Pad Prism 7, Illustrator, Alakazam from the 
Change-O toolkit (http://clip.med.yale.edu/changeo.) and BRepertoire (http://mabra.biomed.kcl.ac.uk/BRepertoire/).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers 
upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The data supporting the findings of this study are available from the corresponding author upon request. RNA sequencing data is available from the public 
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repository on the National Center for Biotechnology Information’s Sequence Read Archive in raw format (BioProject: PRJNA417372; BioSample accession: 
SAMN07985450, SAMN07985451, SAMN07985452, SAMN07985453, SAMN07985454, SAMN07985455).
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For a reference copy of the document with all sections, see nature.com/authors/policies/ReportingSummary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No statistical method was used to predetermine sample size. Sample sizes were chosen based on previous experience with the experimental 
protocols. The antibody responses examined in this work were highly reproducible with little variability. Carcinogenesis experiments have a 
greater biological variation, however the protocols are well-known, and much previous experience guided us to increase our samples sizes to 
minimum 10 animals per experimental group to ensure statistical power in these longitudinal studies.
Data exclusions No data points were excluded from data sets.
Replication All the experimental data provided are based on biological replicates and are representative of independent experiments. All experiments 
were reliably reproduced.
Randomization For animal work, mice of a particular genotype were randomly selected for experiment from a larger cohort - other than that, no 
randomization was used. 
For human tissue, individual SSC tumours were graded by an experienced dermatopathologist as low risk or high risk based on the Scottish 
Intercollegiate Guidelines Network for cutaneous SCC, as outlined in the materials and methods.
Blinding For reporting on tumour development following chemically induced carcinogenesis, back skin and tumours were evaluated by an observer 
blinded to the experimental groups. For most other experiments, the investigators were not blinded to group allocation.
Reporting for specific materials, systems and methods
Materials & experimental systems
n/a Involved in the study
Unique biological materials
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
Antibodies
Antibodies used For all flow cytometry staining, cell suspensions were incubated with 2% Rat Serum (Sigma) and Fc block (clone 93, BD 
Bioscience) for 30mins on ice, prior to staining. The following antibodies were then used: eBioscience: anti-CD45 (30-F11), B220 
(RA3-6B2), ), CD95 (Jo2), GL7 (GL-7), IgE (23G3), IgG1 (M1-14D12), TCRβ (H57-597), TCRγδ (eBioGL3), Vγ5 (536), CD117 (2B8), 
IL-4 (11B11); BD Biosciences: CD38 (90/CD38), CD138 (281-2), IgG2a (R19-15); Biolegend: CD41 (MWReg30), FcεRI (MAR-1), IL-6 
(MP5-20F3), CD63 (NVG-2), Vγ4 (UC3-10Ab), CD3 (145-2C11); Millipore:, γH2AX (JBW301). All antibodies were used at a 
dilution of 1:100-1:200 as per respective manufacturers recommendation. 
OVA-loaded tetramers were provided by the NIH tetramer facility - Emory University Vaccine Center 954 Gatewood Road 
Atlanta, GA 30329. Reagents are provided to qualified investigators at no cost.
Validation All antibodies were validated by the manufacturers and by our own and colleagues' labs where they are used extensively. All 
antibodies were titrated to determine optimal staining concentration.
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Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals Only mice were used in this study and groups were age- and sex-matched for all experiments. In general females mice at 7-9 
weeks were used throughout . Tcrd-/-, Tcrb-/-, IL4-/-, Langerin-DTA (LC-deficient) and Vg5Vd1-/- were on the FVB/N background 
after >10 backcrosses; Igh-7-/-, FceR1a-/- and Cpa3Cre/+ were on the BALB/c background after >10 backcrosses; and OTII Tg, 
Tcrb-/-, CD19-Cre and Bcl6fl/fl were on the C57BL/6 background. Genetic backgrounds of individual strains and controls are 
indicated where appropriate. Humoral responses were also examined in male animals and were comparable. 
All mouse studies were approved by Imperial College AWERB (Animal Welfare and Ethical Review Body) and by the UK Home 
Office. Experiments involving cancer studies strictly adhered to the guidelines set out by the National Cancer Research Institute 
(NCRI) and Workman et al. in ‘Guidelines for the Welfare and Use of Animals in Cancer Research’. All studies using mice were 
conducted following the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines.
Wild animals n/a
Field-collected samples n/a
Human research participants
Policy information about studies involving human research participants
Population characteristics Two cohorts of human research participants were involved in this study: 
A: freshly excised SSC tumour tissue and peri-lesional skin for flow cytometric analysis from 12 patients: All tumor tissue used in 
the study was confirmed SSCs with a diameter > 8mm. Non-lesional skin was histopathologically normal and > 6mm away from 
the tumor edge.  
B: For SSC tumor gene expression, fixed frozen paraffin embedded skin samples from 56 patients obtained from the University of 
Dundee, Tayside NHS Trust and Greater Glasgow and Clyde NHS Trust were analyzed.
Recruitment In A: freshly excised SCC tissue and peripheral blood were obtained from 12 patients during surgery at the Dermatology 
Department, University Hospital Southampton NHS Foundation Trust. Ethics were provided by the South Central Hampshire B 
NRES Committee (reference number 07/H0504/187). All participants recruited to the study provided informed consent for blood 
and tissue samples to be used for research purposes. 
In B: The study was conducted according to the Declaration of Helsinki Principles and all patients donating samples to this study 
provided written, informed consent in accordance with ethical approval from the East of Scotland Research Ethics Service 
(EoSRES) REC 1. SSC tumors were graded by an experienced dermatopathologist as low risk or high risk based on the Scottish 
Intercollegiate Guidelines Network for cutaneous SCC. In addition, peri-lesional skin (histopathologically normal looking skin > 4 
mm away from the tumor edge) and abdominal non-UV exposed skin were also analyzed.
Flow Cytometry
Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Tumour tissue, skin, skin-draining LNs, spleens and blood were collected and processed using standard methods as detailed in 
the Material and Methods section.
Instrument BD FACSVerse and BD LSRFortessa X-20
Software BD FACS DIVA software version 8.0.1 and FlowJo software, version 8.8.7 and version 10
Cell population abundance For cell sorting: 10,000 to 200,000 cells were collected for each population. The purity of each population was over 95% and was 
determined by rerunning the sorted population on a FACS. 
For FACS analysis: the population abundance varied in different tissues and in different analysis - the relevant cell abundance is 
indicated within the results section.
Gating strategy Flow cytometric analysis focused around identifying activated B cells, mainly germinal center B cells (GC B cells) and antibody-
secreting plasma cells (PCs). In all experiments, cells were first gated on singlets (FSC-H vs FSC-A) before setting a lymphocyte 
gate based on SSC-A vs FSC-A. Dead cells and T cells were excluded from the analysis by using a Live/Dead dye (Invitrogen) and 
pan CD3 antibody respectively. GC B cells were gated as B220+, CD95+ GL7+. PCs were identified as FSChi, CD95+, CD138+. 
Additional intracellular staining was carried out to assess isotype class switching. Isotype control antibodies were used to 
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determine if the staining was specific. Fluorescence Minus One (FMO) controls were used to determine the gating boundaries.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
